GlassScriptPhysician profile
Gamaliel Immanuel
NPI 1598855231
$4,182.19
in general payments reported to CMS, 2019-2025
16 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $295 · 2021: $1,017 · 2022: $1,130 · 2023: $541 · 2024: $328 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,383.33 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $1,092.05 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $417.76 | 2019-2022 | |
| Allergan, INC. | $317.83 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $153.68 | 2019-2021 | |
| Celgene Corporation | $147.82 | 2021-2023 | Zeposia |
| Qol Medical, LLC | $145.65 | 2019-2023 | Sucraid |
| Phathom Pharmaceuticals, INC. | $143.80 | 2024-2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $119.33 | 2019-2024 | Linzess |
| Ardelyx, INC. | $85.39 | 2022-2024 | Ibsrela |
| Exact Sciences Corporation | $49.25 | 2024 | Cologuard Collection Kit |
| Alfasigma USA, INC. | $39.18 | 2020-2021 | |
| Redhill Biopharma INC. | $33.68 | 2020 | |
| Intra-Sana Laboratories | $18.88 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $18.73 | 2024 | Iqirvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $15.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gamaliel Immanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.